T <= 2N0 TRG1-2 in Post-Chemoradiation Therapy MRI: What can it Predict?

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2019
Scopus
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
SURGICAL TECHNOLOGY INT ONLINE
Autores
Citação
SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH, v.35, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Total mesorectal excision is the standard radical operation after neoadjuvant chemoradiotherapy for patients with middle/low locally advanced rectal cancer. However, it carries significant rates of morbidity, sexual/urinary dysfunction, fecal impairment and permanent stoma. The ability to identify patients with a complete or nearly-complete response could help steer patients to less-invasive surgery or a watch-and-wait strategy. Objective: To assess the ability to predict good responders and a favorable prognosis among rectal cancer patients by post-chemoradiation therapy MRI. Patients: Consecutive patients stage T3-4N0M0 or T(any)N+M0 located within 10cm from the anal verge were enrolled. Patients were staged and re-staged 8.8 weeks after the completion of chemoradiation by digital exam, colonoscopy, pelvic-MRI, and thorax and abdominal CT scans. All patients underwent total mesorectal excision with curative intent. Results: Of the total 309 patients, 275 were eligible, and 199 (72.4%) of these were stage III. Restaging-MRI identified 59 (21.4%) T <= 2N0/TRG1-2. Specimen pathologic evaluation revealed 43 (15.6%) patients with a complete pathologic response. Estimates of the accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of MRIyT=2N0/TRG1-2 for the identification of ypT0N0 were 79.7%, 84.5%, 53.5%, 39%, and 90.7%, respectively. Estimates for the identification of ypN0 were 48.4%, 27.8%, 92%, 88.1%, and 48.4%, respectively. In a multivariate analysis, the only pre-CRT/MRI variables that were associated with an increased risk of lymph node involvement at the specimen were N+ (OR=2.22) and extramural vascular invasion (OR=2.28). MRI yT <= 2N0/TRG1-2 patients showed improved estimated 5-year disease-free survival, but no difference in estimated 5-year survival. Conclusion: Although MRIyT <= 2N0/TRG1-2 cannot predict all cases of a complete pathologic response, it can effectively predict a low rate of lymph node involvement and a better prognosis in patients who undergo total mesorectal excision.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/37750
Referências
  1. Allen SD, 2007, AM J ROENTGENOL, V188, P442, DOI 10.2214/AJR.05.1967
  2. Araujo SEA, 2011, INT J COLORECTAL DIS, V26, P1359, DOI 10.1007/s00384-011-1131-x
  3. Beddy D, 2008, ANN SURG ONCOL, V15, P3471, DOI 10.1245/s10434-008-0149-y
  4. Bhoday J, 2016, DIS COLON RECTUM, V59, P925, DOI 10.1097/DCR.0000000000000667
  5. Chen CC, 2005, DIS COLON RECTUM, V48, P722, DOI 10.1007/s10350-004-0851-1
  6. Dalton RSJ, 2012, COLORECTAL DIS, V14, P567, DOI 10.1111/j.1463-1318.2011.02752.x
  7. Dossa F, 2017, LANCET GASTROENTEROL, V2, P501, DOI 10.1016/S2468-1253(17)30074-2
  8. Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
  9. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  10. Habr-Gama A, 2004, ANN SURG, V240, P7
  11. Junginger T, 2010, DIS COLON RECTUM, V53, P1632, DOI 10.1007/DCR.0b013e3181ed0aae
  12. Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580
  13. Maas M, 2015, ANN SURG ONCOL, V22, P3873, DOI 10.1245/s10434-015-4687-9
  14. MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
  15. Marks JH, 2009, SURG ENDOSC, V23, P1081, DOI 10.1007/s00464-009-0326-5
  16. Marques CFS, 2016, INT J COLORECTAL DIS, V31, P833, DOI 10.1007/s00384-016-2527-4
  17. Mignanelli ED, 2010, DIS COLON RECTUM, V53, P251, DOI 10.1007/DCR.0b013e3181bcd3cc
  18. Nahas SC, 2016, DIS COLON RECTUM, V59, P255, DOI 10.1097/DCR.0000000000000558
  19. Onaitis MW, 2001, ANN SURG ONCOL, V8, P801, DOI 10.1245/aso.2001.8.10.801
  20. Pahlman L, 1997, NEW ENGL J MED, V336, P980
  21. Patel UB, 2011, J CLIN ONCOL, V29, P3753, DOI 10.1200/JCO.2011.34.9068
  22. Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3
  23. Pucciarelli S, 2005, ANN SURG ONCOL, V12, P111, DOI 10.1245/ASO.2005.03.044
  24. Read TE, 2004, DIS COLON RECTUM, V47, P825, DOI 10.1007/s10350-004-0535-x
  25. Rullier E, 2017, LANCET, V390, P469, DOI 10.1016/S0140-6736(17)31056-5
  26. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  27. Smith FM, 2006, EJSO-EUR J SURG ONC, V32, P55, DOI 10.1016/j.ejso.2005.09.010
  28. Stipa F, 2004, ANN SURG ONCOL, V11, P187, DOI 10.1245/ASO.2004.06.010
  29. Taylor FGM, 2014, J CLIN ONCOL, V32, P34, DOI 10.1200/JCO.2012.45.3258
  30. van den Broek JJ, 2017, DIS COLON RECTUM, V60, P274, DOI 10.1097/DCR.0000000000000743
  31. Zmora O, 2004, DIS COLON RECTUM, V47, P1607, DOI 10.1007/s10350-004-0673-1

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/35
Carregar mais